To evaluate effectiveness of aclidinium bromide/formoterol fumarate dihydrate in chronic obstructive pulmonary disease - ASTUTE

Study identifier:D6570R00004

ClinicalTrials.gov identifier:NCT03181880

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

To evaluate effectiveness of aclidinium bromide/formoterol fumarate dihydrate in chronic obstructive pulmonary disease

Medical condition

Chronic Obstructive Pulmonary Disease

Phase

Phase 4

Healthy volunteers

No

Study drug

Aclidinium bromide/formoterol fumarate combination, Standard of Care

Sex

All

Actual Enrollment

0

Study type

Interventional

Age

40 Years +

Date

Study Start Date: 04 Dec 2017
Estimated Primary Completion Date: 03 Dec 2018
Estimated Study Completion Date: 03 Dec 2018

Study design

Allocation: Randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jun 2017 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

QUINTILESIMS INC

Inclusion and exclusion criteria